BI

BVF Inc Portfolio holdings

AUM $2.47B
1-Year Est. Return 71.28%
This Quarter Est. Return
1 Year Est. Return
+71.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$986M
AUM Growth
+$157M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$85.5M
2
+$44.8M
3
+$27M
4
RCUS icon
Arcus Biosciences
RCUS
+$19.6M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$17.2M

Top Sells

1
+$59.1M
2
+$23.7M
3
+$21.7M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$14.1M
5
CASC
Cascadian Therapeutics, Inc.
CASC
+$11.6M

Sector Composition

1 Healthcare 83.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$10.8M 1.1%
4,355
-3,555
27
$10.3M 1.05%
679,302
+185,714
28
$10M 1.02%
116,452
29
$8.16M 0.83%
228,083
+40,583
30
$7.5M 0.76%
+161,307
31
$7.33M 0.74%
+225,000
32
$5.98M 0.61%
1,345
-139
33
$5.57M 0.56%
4,375
34
$5.51M 0.56%
45,909
-2,366
35
$5.41M 0.55%
675,759
36
$5.25M 0.53%
+625,000
37
$4.58M 0.46%
48,132
-10,245
38
$3.53M 0.36%
720,830
-2,868,000
39
$3.48M 0.35%
405,600
+111,483
40
$2.04M 0.21%
4,474
41
$1.94M 0.2%
+509,182
42
$506K 0.05%
4,386
43
$108K 0.01%
534,900
-200,076
44
– –
-1,124,483
45
– –
-4,975
46
– –
-325,509
47
– –
-273,350
48
– –
-1,608,433
49
– –
-1,216,403
50
– –
-3,133,224
1
2